Search

The Power of Global Standardization: Unlock High Quality Flow Cytometry Results

Federica De Paoli, PhD

Flow Cytometry can interrogate multiparametric measurements on individual cells and has become a widely used specialty testing platform for clinical t...

October 11, 2023 1:00pm

HER2 Testing: Towards a Brighter Future

Dr. Sangeeta Desai, Dr. Suseela Kodandapani and Dr. Veena R

This webinar, sponsored by Roche, provided valuable insights into the latest advances in HER2 diagnostics in breast cancer. Dr. Sangeeta Desai, Profes...

6 months ago 76 mins

Using the Lumin Platform to Build Prediction Models of Olaparib Sensitivity Day2

Clare Killick-Cole, PhD & Art Hanson, MSCS

Day 2: Enriching your Multi-omic Dataset and Building Highly Predictive Models of Response Sensitivity Learn more about these topics by registering ...

1 year ago 48 mins

Lung Cancer Biomarker Testing

Dr. Paul A. Bunn Jr, MD

Lung Cancer Biomarker Testing presented by Dr. Paul A. Bunn Jr, MD, Distinguished Professor and Dudley Endowed Chair University of Colorado Cancer Cen...

4 years ago 20 mins

Cost effectiveness analysis of PD-L1 testing in NSCLC - IVD vs LDT

Jason Hurwitz, BA, MA, Phd; Shannon Vaffis, MPH, Phd; Amy Grizzle, BA, Pharm D

This webinar will share compelling research that evaluated the cost-effectiveness of PD-L1 testing with an in vitro diagnostic (IVD) compared to a lab...

12 months ago 45 mins

NTRK Testing: Practical Considerations for IHC Interpretation

Dr. Lawrence Weiss and Dr. Fernando López-Ríos

As pan-TRK IHC evaluation becomes a more integrated part of NTRK testing in clinical practice, take the opportunity to learn from Dr. Lawrence Weiss (...

2 years ago 120 mins

PathAI PD-L1(28-8)integration on Roche navify Digital Pathology open environment

Eric Walk, MD, Chief Medical Officer, PathAI

In this webinar, Dr. Walk will discuss how PathAI aims to improve cancer patient outcomes using the power of Artificial Intelligence, the importance o...

5 months ago 60 mins

HER2-Low: a new category of patients who benefit from HER2-targeted therapy

Dr. David Hicks, University of Rochester and Dr. Sunil Badve, Emory University

In this webinar, Drs. Hicks and Badve will discuss the latest advances in HER2 immunohistochemical testing and interpretation, with a focus on the eme...

3 months ago 53 mins

Validation of Low Prevalence Biomarkers in the Laboratory

Dr. Dylan Miller, University of Utah, Utah USA and Dr. Emina Torlakovic, University of Saskatchewan, Saskatoon, SK Canada

In this BrightTALK webinar, Dr. Dylan Miller and Dr. Emina Torlakovic will discuss approaches and perspectives on validation of low prevalence biomark...

3 years ago 76 mins

Immunohistochemistry detection of DNA mismatch repair in colorectal cancer

Dr. Weiqi Sheng, Fudan University Shanghai Cancer Center & Dr. Ying Kong, Roche Diagnostics Solutions

This webinar, sponsored by Roche, aims to provide an understanding of the scientific development and significance of DNA mismatch repair (MMR) deficie...

1 year ago 45 mins

Search results